Log in

OTCMKTS:AKZOFAkzo Nobel Stock Price, Forecast & News

$78.44
0.00 (0.00 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$78.44
Now: $78.44
$78.44
50-Day Range
$63.55
MA: $72.56
$78.44
52-Week Range
$54.96
Now: $78.44
$99.55
Volume467 shs
Average Volume5,597 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Akzo Nobel N.V. operates as a paints and coatings company worldwide. The company offers decorative paints, including paints, lacquers, and varnishes; a range of mixing machines and color concepts for the building and renovation industry; and specialty coatings for metal, wood, and other building materials primarily under the Dulux, Coral, Levis, and Flexa brands. It also provides performance coatings to protect and enhance ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities. The company was formerly known as Akzo NV and changed its name to Akzo Nobel N.V. in 1994. Akzo Nobel N.V. was founded in 1646 and is headquartered in Amsterdam, the Netherlands.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
SectorBasic Materials
Current SymbolOTCMKTS:AKZOF
CUSIPN/A
CIKN/A
Phone31 88 969 7555

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees34,400
Next Earnings DateN/A
OptionableNot Optionable

Receive AKZOF News and Ratings via Email

Sign-up to receive the latest news and ratings for AKZOF and its competitors with MarketBeat's FREE daily newsletter.

Akzo Nobel (OTCMKTS:AKZOF) Frequently Asked Questions

How has Akzo Nobel's stock been impacted by COVID-19 (Coronavirus)?

Akzo Nobel's stock was trading at $79.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AKZOF stock has decreased by 1.8% and is now trading at $78.44. View which stocks have been most impacted by Coronavirus.

Has Akzo Nobel been receiving favorable news coverage?

News headlines about AKZOF stock have been trending extremely positive on Wednesday, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Akzo Nobel earned a coverage optimism score of 5.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutAkzo Nobel.

Who are some of Akzo Nobel's key competitors?

Who are Akzo Nobel's key executives?

Akzo Nobel's management team includes the following people:
  • Mr. Thierry F. J. Vanlancker, Chairman of Management & CEO (Age 55)
  • Mr. Maarten Jan de Vries, CFO & Member of Management Board (Age 57)
  • Mr. Ruud Joosten, Chief Operating Officer (Age 55)
  • Mr. Lloyd Midwinter, Director of Communications & Investor Relation
  • Ms. Isabelle Deschamps, Gen. Counsel (Age 49)

What is Akzo Nobel's stock symbol?

Akzo Nobel trades on the OTCMKTS under the ticker symbol "AKZOF."

How do I buy shares of Akzo Nobel?

Shares of AKZOF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Akzo Nobel's stock price today?

One share of AKZOF stock can currently be purchased for approximately $78.44.

What is Akzo Nobel's official website?

The official website for Akzo Nobel is www.akzonobel.com.

How can I contact Akzo Nobel?

The company can be reached via phone at 31 88 969 7555.

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.